Nickel, chromium and cobalt in consumer products: revisiting safe levels in the new millennium
Authors: Basketter D.A.1; Angelini G.2; Ingber A.3; Kern P.S.4; Menné T.5
Source: Contact Dermatitis, Volume 49, Number 1, July 2003 , pp. 1-7(7)
Publisher: Blackwell Publishing
Abstract:
The transition metals nickel (Ni), chromium (Cr) and cobalt (Co) are common causes of allergic contact dermatitis (ACD). Given the high frequency with which these allergens can be associated with hand eczema in those responsible for domestic work, it has been suggested that contamination of household consumer products with these metals may be of relevance to the causation/chronicity of hand dermatitis. Doseresponse studies using 48 h occlusive patch test conditions in sensitized individuals show that
90% of sensitized patients fail to react below 1 p.p.m., even on irritated skin. Assessment under more realistic exposure conditions has shown that in the presence of irritants and/or following repeated exposures, such individuals rarely react to levels below 10 p.p.m. On the basis of this information, it was recommended a decade ago that household (and other consumer) products should not contain more than 5 p.p.m. of each of Ni, Cr or Co and that, for an even greater degree of protection, the ultimate target level should be 1 p.p.m. The data generated since the original recommendations were made serve to reinforce the validity of these recommendations. Indeed, it is our view that typically the level of each of these transition metals should not normally exceed 1 p.p.m. Then, where consumer products meet this guideline fully, modern quantitative risk assessment shows clearly that elicitation of ACD is highly improbable, and the chance of the induction of sensitization is even lower.
Keywords: nickel; chromate; cobalt; thresholds; consumer products; elicitation
Document Type: Review article
DOI: 10.1111/j.0105-1873.2003.00149.x
Affiliations: 1: Safety and Environmental Assurance Centre, Unilever Colworth, Sharnbrook, Bedford, UK, 2: Department of Internal Medicine, Immunology and Infectious Diseases Unit of Dermatology, University of Bari, Italy, 3: Department of Dermatology, Haddassah Hospital, Ein Kerem, Jerusalem, Israel, 4: Procter & Gamble, European Technical Center, Strombeek-Bever, Belgium, 5: Department of Dermatology, Gentofte Hospital, Hellerup, Denmark

Click here for Page Help